THEOLYTICS
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
THEOLYTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-12-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.theolytics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Microsoft Azure DNS Google Google Cloud
Similar Organizations
Agathos Biologics
Agathos Biologics is a biotechnology company developing transformational science within a strong ethical and moral framework.
AI4R
AI4R engages in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Apoglyx
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Carcell Biopharma
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Engimmune Therapeutics
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
eureKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
FimmCyte
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
GeneMedicine
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
HEPHAISTOS-Pharma
HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies.
Innatera Nanosystems
Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
Innoskel
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Mediar Therapeutics
Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis.
NAVAN Technologies
NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies
Olgram
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Opal Biosciences
Opal Biosciences is a preclinical-stage biotechnology company specializing in treating infectious diseases.
PamBio
PamBio is a pre-clinical stage biotechnology company developing drug therapy for acute bleeding conditions.
PEP-Therapy
Innovative peptides as targeted therapies for oncology
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Saftra Photonics
Saftra Photonics is a Slovak high-tech company established as a spin-off from the P. J. Safarik University, Kosice, Slovakia in 2014.
TandemAI
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Unibio
Unibio provides sustainable protein services for the biotechnology sector.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Theolytics
Epidarex Capital
Epidarex Capital investment in Series A - Theolytics
Taiho Ventures
Taiho Ventures investment in Series A - Theolytics
M Ventures
M Ventures investment in Series A - Theolytics
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Theolytics
Official Site Inspections
http://www.theolytics.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.29 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Theolytics"
Theolytics - Crunchbase Company Profile & Funding
Theolytics is a clinical stage biotechnology company harnessing viruses to combat disease. A step-change in the adenoviral therapy field, our phenotypic screening Platform enables the …See details»
Theolytics' Leadership Team - Team members and org chart | The …
Other teams at Theolytics. View all +4. Board of Directors. 7 members +1. Founding Team. 4 members. Discover similar companies. Charm Therapeutics. Venture · London, United …See details»
Team - Theolytics
Our team is one of the most important elements of who we are and what we do. We combine world leading scientific expertise – spanning virology, cancer biology, immunology, …See details»
Theolytics Company Profile 2024: Valuation, Funding & Investors
Theolytics General Information Description. Operator of the phenotypic screening platform intended to harness viruses to combat cancer. The company focuses on developing category …See details»
Theolytics | VentureRadar
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. The company was formed in 2017 to drive the development of a pipeline of …See details»
Theolytics Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Theolytics, a clinical biotech firm, is pioneering the use of viruses to fight diseases. As a game-changer in adenoviral therapy, their phenotypic screening platform facilitates the identification …See details»
Theolytics Company Profile - Office Locations, Competitors, …
Theolytics has 5 employees at their 1 location and $6.8 m in total funding,. See insights on Theolytics including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Technology - Theolytics
At Theolytics we are focused on harnessing viruses to combat disease. Our discovery platforms leverage systematic phenotypic screening technologies to power the discovery of therapies …See details»
Theolytics successfully closes latest financing raising total of £19M ...
Theolytics, a biotechnology company developing next-generation oncolytic viral therapies, today announced it has successfully closed its latest financing round, raising a total of £19M ($24.5M ...See details»
Theolytics - Oxford Science Enterprises
Theolytics is a pre-clinical biotech company harnessing oncolytics viruses to treat cancers, utilising systematic phenotypic screening and selection systems optimised for translational …See details»
Theolytics successfully closes latest financing raising total of £19M ...
Oxford, UK April 17th, 2024. Theolytics, a biotechnology company developing next-generation oncolytic viral therapies, today announced it has successfully closed its latest financing round, …See details»
Theolytics - Overview, News & Similar companies | ZoomInfo.com
Apr 1, 2024 Sound Bioventures joins £19M ($24.5M) financing in UK oncolytic virus company Theolytics Stockholm, Sweden and Washington D.C., USA – 17 April 2024 - Sound …See details»
Theolytics - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Mike Grey appointed Executive Chair of Theolytics’ Board of …
Mar 21, 2024 Mike brings decades of operational and board experience gained in Pharma, Biotech and Venture Capital to TheolyticsOxford, UK, March 21st 2024 — Theolytics, a …See details»
Theolytics - Contacts, Employees, Board Members, Advisors
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.See details»
Theolytics Ltd | CipherBio
Explore Theolytics Ltd's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Theolytics presents CAF-targeting therapy for stromal rich …
Oxford, UK, 6th October 2022 - Theolytics, a biotechnology company harnessing viruses to combat disease, will release data on their proprietary systemic therapy for stromal-rich …See details»
Theolytics presents CAF-targeting therapy for stromal rich …
Oct 6, 2022 Theolytics, which was founded in 2017 and is headquartered in Oxford, UK, backed by OxSciences and international life sciences investors Epidarex Capital, Taiho Ventures, and …See details»
Theolytics expands Series A financing and welcomes M Ventures …
Theolytics is harnessing viruses to combat cancer: transforming patients’ lives; through world leading science; with a great team.Oxford, UK, 8th July 2021M Ventures – the strategic …See details»